i3.1®

i3.1®
Product Description

i3.1® Targeted IBS Relief Probiotic offers clinically proven treatment for irritable bowel syndrome (IBS). Combining three powerful strains—Pediococcus acidilactici KABP™ 021, Lactobacillus plantarum KABP™ 022, and Lactobacillus plantarum KABP™ 023—it helps improve digestion, ease stress-related digestive disorders, and enhance intestinal transit. With 3 billion CFU per dose, it is supported by the World Gastroenterology Organisation as an effective solution for managing IBS and other other disorders of gut-brain interaction (DGBI). i3.1® finished as finalist in NutraIngredients Awards World 2023. 

Ab Biotics S.A

  • Country/Region:
    Spain
  • On CPHI since:
    2022
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
Primary activities
Clinical Research
Nutraceuticals
Pharmaceutical Company (innovator finished products)

Ab Biotics S.A

  • Country/Region:
    Spain
  • On CPHI since:
    2022
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
Primary activities
Clinical Research
Nutraceuticals
Pharmaceutical Company (innovator finished products)

More Products from Ab Biotics S.A (7)

  • AB-KOLICARE®

    Product AB-KOLICARE®

    AB-KOLICARE® is a probiotic formula comprising 2 bacterial strains (B. longum KABP™ 042/CECT 7894 and P. pentosaceus KABP™ 041/CECT 8330) that possess multiple beneficial properties for neonates and toddlers. Clinically tested in 150 babies, it is an easy-to-use, completely natural and safe solution for ba...
  • AB-PROTEARS®

    Product AB-PROTEARS®

    AB-PROTEARS® is an innovative Class IIb Medical Device (MDR) based on a postbiotic, the heat-inactivated lysate of Latilactobacillus sakei proBio 65, for the care and protection of the ocular surface. It works through two complementary mechanisms: reducing pro-inflammatory cytokines and reinforcing the pro...
  • Gyntima® Menopause

    Product Gyntima® Menopause

    Gyntima® Menopause is a probiotic formula combining 3 bacterial strains (L. plantarum KABP® 051, L. brevis KABP® 052 and P. acidilactici KABP® 021), developed to promote hormonal balance during menopause. Through modulation of the gut estrobolome it slows down estrogen decline, and has been shown to allevi...
  • AB21®

    Product AB21®

    AB21® is a unique combination of 4 bacterial strains (L. plantarum KABP™ 033/ CECT 30292, L. plantarum KABP™ 022/CECT 7484, L. plantarum KABP™ 023/CECT 7485 and P. acidilactici KABP™ 021/CECT 7483) that has been shown to reduce and prevent symptoms of viral infection...
  • INNERIM®

    Product INNERIM®

    INNERIM® is a probiotic formula comprising 2 bacterial strains (L. plantarum KABP® 031 and L. plantarum KABP® 032) that possess multiple beneficial properties for adults aged 50+. Backed by 6 scientific publications including 4 clinical trials in 250 adults aged 50–85, it supports digestive regularity in o...
  • LipiGO®

    Product LipiGO®

    LipiGO® two main ingredients are β-glucan and chitin-chitosan, two polysaccharides found in the yeast cell wall. This postbiotic formulation has been clinically proven to increase the elimination of saturated fats with every meal by 75%, without compromising nutritional intake. The product was developed as...
  • MINDBIOME®

    Product MINDBIOME®

    MINDBIOME® is a psychobiotic based on L. plantarum DR7® (KABP® 051) that modulates the gut-brain axis to promote emotional and physical wellbeing. Clinically proven to counteract the effects of chronic stress and anxiety, it reduces cortisol levels and improves memory and cognitive function, while als...

Ab Biotics S.A resources (1)

  • Brochure Portfolio 2026- AB-BIOTICS: Bringing probiotics to life

    AB-Biotics is a leading global player in the development of scientifically documented probiotic solutions tailored to meet diverse health needs. Our premium probiotic products are designed to improve gastrointestinal, immune, skin, cognitive, cardiometabolic, women’s, pediatric, and oral health. We specialize in unique strains backed by robust clinical evidence and patented technologies, ensuring safety, efficacy, and adaptability to various market demands.